Lumira Ventures partners with exceptional entrepreneurs to build life science companies that transform the lives of patients worldwide.
Lumira News
Lumira continues to support those most affected by the COVID-19 pandemic
July 9, 2020
With a surge in new cases surpassing daily highs across the US, it is clear that the battle against COVID-19 will continue for the foreseeable future. While much of the world tries to go back to... Learn More
HistoSonics Announces $40 Million Financing
June 8, 2020
Breakthrough medical platform offers vision of non-invasive procedures to eliminate diseased tissues and tumors MINNEAPOLIS, June 8, 2020 /PRNewswire/ -- HistoSonics, developer of a... Learn More
UCB Acquires Engage Therapeutics: Staccato® Alprazolam – A potential Solution for Acute On-demand Seizure Management for People Living With Epilepsy
June 5, 2020
- Staccato® Alprazolam could be a potential solution for 20-30% of epilepsy patients - Initial upfront payment of US$ 125 million and further potential milestone payments of up to US$ 145... Learn More
Forbius Reported Safety and Initial Anti-Fibrotic Effects of First-in-Class, Selective TGF-beta Inhibitor, AVID200, in Phase 1b Systemic Sclerosis Trial at EULAR 2020
June 5, 2020
Initial results demonstrate anti-fibrotic effects of AVID200 as indicated by rapid and sustained declines in skin fibrosis.AVID200 was well-tolerated, and no dose-limiting toxicities, SAEs or... Learn More
Team Lumira
Our investment team of 9 professionals has over 225 years of collective experience founding, managing and investing in healthcare and life sciences companies. We value collaboration, creativity and challenging conventional wisdom.
Philanthropy
Lumira donates a portion of partner time and profits to support the research, translational medicine and healthcare access missions of over a dozen leading healthcare foundations.
Contact Us
Our team is strategically situated across North America to identify innovative companies within and outside the traditional start-up hubs, and help them access capital, talent and strategic partners.
Toronto
141 Adelaide Street
Suite 770
Toronto, ON
Canada, M5H 3L5
416.213.4223
Montreal
Espace CDPQ
3, Place Ville Marie
Bureau 12350, Niveau L
Montreal, QC
Canada, H3B 0E7
514.844.6927
Vancouver
1021 West Hastings Street,
9th floor
Vancouver, BC
Canada, V6E 0C3
604.558.5156
Boston
303 Wyman Street
Suite 300
Waltham, MA,
USA, 02451-1208
781.530.3868